Perrigo Co (MEX:PRGON) Other Financing: MXN-415 Mil (TTM As of Mar. 2026)


MEX:PRGON Perrigo Co PLC MEX:PRGON
44 GF Score
Price MXN557.52
GF Value MXN1,468.70
! 4 Warning Signs
View Full Analysis

What is Perrigo Co Other Financing?

Perrigo Co MEX:PRGON 44 Other Financing is MXN-415 Mil as of Mar. 2026. GuruFocus rates MEX:PRGON with a GF Score™ of 44/100 and a GF Value™ of MXN1,468.70. The stock has 4 warning signs investors should review.

Perrigo Co's Other Financing for the three months ended in Mar. 2026 was MXN-157 Mil.

Perrigo Co's Other Financing for the trailing twelve months (TTM) ended in Mar. 2026 was MXN-415 Mil.

Perrigo Co Other Financing Historical Data

* Premium members only.

The historical data trend for Perrigo Co's Other Financing can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Perrigo Co Other Financing Chart

Perrigo Co Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Other Financing
Get a 7-Day Free Trial Premium Member Only Premium Member Only -379.51 -1,027.44 -123.91 -431.71 -475.35

Perrigo Co Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Other Financing Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -253.68 -118.62 -34.85 -104.43 -156.88
MEX:PRGON
44GF Score
Perrigo Co PLC MEX:PRGON
Other Financing is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Perrigo Co Other Financing Calculation

Other Financing represents other cash flow from financing activity that not otherwise classified, which includes:
Proceeds From Stock Option Exercised
Other Financing Charges

Other Financing for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was MXN-415 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Other Financing →
What does a Other Financing of MXN-415 Mil mean?
Perrigo Co (MEX:PRGON) has a Other Financing of MXN-415 Mil as of Mar. 2026. Other Financing represents other cash flow from financing activity that not otherwise classified. View historical data for Perrigo Co and its competitors.
Is Perrigo Co's Other Financing too high?
Perrigo Co's current Other Financing is MXN-415 Mil. Overall, Perrigo Co has a GF Score™ of 44/100, reflecting its overall financial health beyond just this single metric.
How does Perrigo Co's Other Financing compare to AMLX and HROW?
Perrigo Co's Other Financing of MXN-415 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Financing for a Drug Manufacturers company?
A good Other Financing depends on the Drug Manufacturers industry context. However, Other Financing should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Financing mean?
A high Other Financing can signal that a stock is expensive relative to its fundamentals. Other Financing represents other cash flow from financing activity that not otherwise classified. View historical data for Perrigo Co and its competitors. Perrigo Co's current Other Financing is MXN-415 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Perrigo Co stock overvalued right now?
Perrigo Co (MEX:PRGON) has a current Other Financing of MXN-415 Mil. The stock's GF Value™ is MXN1,468.70, compared to a current price of MXN557.52 — trading 62% below its estimated fair value. The current Other Financing is MXN-415 Mil. Perrigo Co's overall GF Score™ is 44/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Financing calculated?
Other Financing is calculated from a company's financial statements. For Perrigo Co (MEX:PRGON), the current Other Financing is MXN-415 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Perrigo Co (MEX:PRGON) Overvalued in 2026?

Based on GuruFocus' analysis, Perrigo Co stock appears to be undervalued. The current stock price of MXN557.52 is trading 62% below its estimated GF Value™ of MXN1,468.70.

Key valuation signals for MEX:PRGON:

  • Other Financing: MXN-415 Mil
  • GF Value™: MXN1,468.70 vs. price of MXN557.52 (62% below fair value)
  • GF Score™: 44/100 with 4 warning signs

No single metric tells the full story. See the MEX:PRGON stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Perrigo Co Business Description

Address The Sharp Building, Hogan Place, Dublin, IRL, D02 TY74
Perrigo is one of the largest consumer health companies in the world. Since 2018, Perrigo has divested its animal health and generic pharmaceuticals businesses to solely focus on consumer self-care. In North America (two-thirds of total sales), the firm's product mix is anchored in private-label consumer health goods, which are sold to major retailers like Walmart, Amazon, Costco, and CVS. Perrigo also plays in Europe, Australia, and parts of Asia where it primarily generates revenue through its national brands, including Compeed, Solpadeine, Coldrex, and ellaOne.
44GF Score

Get the complete analysis for MEX:PRGON

Other Financing is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

MXN557.52
Price
MXN1,468.70
GF Value